http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2020009657-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2019-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62e207045461945bafb02f592cc0dfee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc9ceeabc16c94791fc67a5f4cdfd8be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_729ca25cd66bbf3d7baf9f0f91ea90c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89593ff85650c49b347f8199cb868297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_174b571c9e76a5499fc46b85ff988b67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2b6a67af3cc1f967b3687982877c61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e9e88e9f26d655dcfdc8e7d6124f054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6e513af1c8f81edaa209e71b299f126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0047b1d17a3d69ebab6eade5550f9b4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6972ba7b0b83ad334ec26eb8c4c07eff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5063a0ce07ae3f3ee3010e53863cc99
publicationDate 2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2020009657-A
titleOfInvention TRANSIENT OXADIAZOLE RECEPTOR POTENTIAL CHANNEL INHIBITORS.
abstract The invention relates to compounds of formula I: (see Formula) and pharmaceutically acceptable salts thereof, wherein A, X, R1, R4 and n are as defined herein. Furthermore, the present invention relates to the method of preparation and methods of use of the compounds of formula I, as well as to pharmaceutical compositions containing the compounds. The compounds may be useful in the treatment of TRPA1-mediated diseases and conditions, such as pain.
priorityDate 2018-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39015
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VJJ7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID312896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419705795
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID277328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10197612
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8989
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID474351

Total number of triples: 54.